Select Page

Drug company faked cancer patients to sell drug

As Seen In:

ABC Nightline logo, featured in the context of showcasing Richard J. Hollawell's successful personal injury case results and media recognition.
New York Times logo featured in the context of Richard J. Hollawell's personal injury law firm showcasing case results and significant settlements.
Logo of Richard J. Hollawell, personal injury attorney, representing successful case results and legal expertise in Pennsylvania, New Jersey, and New York.
The Wall Street Journal logo, representing media coverage of Richard J. Hollawell's successful personal injury law practice.
Image depicting case results and legal achievements of Richard J. Hollawell, showcasing significant settlements in personal injury law, including a $9 million settlement related to fentanyl distribution violations.

GET A FREE CONSULTATION

Practice Areas: Personal Injury, Medical Malpractice & Opioid Cases

RECENT RESULTS

$4.5M wrongful death settlement due to opioid overprescription, highlighting legal advocacy for personal injury victims in Camden County.
Motor vehicle accident settlement of $1.7M due to drunk driver negligence, highlighting successful personal injury case results.
$750K settlement for personal injury case involving a tractor trailer accident, highlighting successful legal representation by Camden County personal injury lawyers.

Washington (CNN) When Insys Therapeutics got approval to sell an ultra-powerful opioid for cancer patients with acute pain in 2012, it soon discovered a problem: finding enough cancer patients to use the drug.

Falsifying Medical Records

To boost sales, the company allegedly took patients who didn’t have cancer and made it look like they did. The drug maker used a combination of tactics, such as falsifying medical records, misleading insurance companies and providing kickbacks to doctors in league with the company, according to a federal indictment and ongoing congressional investigation by Sen. Claire McCaskill, a Democrat from Missouri.The new report by McCaskill’s office released Wednesday includes allegations about just how far the company went to push prescriptions of its sprayable form of fentanyl, Subsys.

Read the full story at CNN.com

    Ready for a no-cost consultation?

    Speak directly to Richard Hollawell today - there is never a fee until we win your case.

    You have Successfully Subscribed!